4406
New Japan Chemical Co.,Ltd.
新日本理化
- Industry
- Chemicals
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2022
32,358
Mar 2023
33,105
Mar 2024
32,863
Mar 2025
32,703
Mar 2026
32,105
Operating profit(million JPY)
Mar 2022
1,202
Mar 2023
-439
Mar 2024
361
Mar 2025
829
Mar 2026
576
Operating profit margin(%)
Mar 2022
3.71
Mar 2023
-1.33
Mar 2024
1.1
Mar 2025
2.53
Mar 2026
1.79
Profit before tax(million JPY)
Mar 2022
930
Mar 2023
-230
Mar 2024
520
Mar 2025
723
Mar 2026
679
Profit(million JPY)
Mar 2022
811
Mar 2023
-444
Mar 2024
220
Mar 2025
522
Mar 2026
597
Total assets(million JPY)
Mar 2022
40,086
Mar 2023
38,553
Mar 2024
40,114
Mar 2025
37,519
Mar 2026
40,345
Cash and cash equivalents(million JPY)
Mar 2022
3,329
Mar 2023
2,771
Mar 2024
3,695
Mar 2025
2,780
Mar 2026
5,532
Cash flows from operating activities(million JPY)
Mar 2022
1,078
Mar 2023
104
Mar 2024
3,578
Mar 2025
-224
Mar 2026
1,643
Cash flows from investing activities(million JPY)
Mar 2022
-1,602
Mar 2023
-659
Mar 2024
-60
Mar 2025
-174
Mar 2026
501
Cash flows from financing activities(million JPY)
Mar 2022
861
Mar 2023
-3
Mar 2024
-2,596
Mar 2025
-513
Mar 2026
-64
Return on equity(%)
Mar 2022
5.2
Mar 2023
-2.8
Mar 2024
1.3
Mar 2025
3
Mar 2026
3.2
Equity ratio(%)
Mar 2022
39.8
Mar 2023
41.2
Mar 2024
43.1
Mar 2025
47.4
Mar 2026
48.9
Earnings per share(JPY per share)
Mar 2022
21.76
Mar 2023
-11.92
Mar 2024
5.92
Mar 2025
14
Mar 2026
16.03
Net assets per share(JPY per share)
Mar 2022
427.44
Mar 2023
425.54
Mar 2024
463.6
Mar 2025
477.07
Mar 2026
529.55
Dividend per share(JPY per share)
Mar 2022
5
Mar 2023
-
Mar 2024
-
Mar 2025
4
Mar 2026
4.5
Payout ratio(%)
Mar 2022
22.98
Mar 2023
-
Mar 2024
-
Mar 2025
28.57
Mar 2026
28.07
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.